KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Assets Average (2016 - 2025)

Historic Assets Average for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $107.9 billion.

  • Eli Lilly's Assets Average rose 4636.26% to $107.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $107.9 billion, marking a year-over-year increase of 4636.26%. This contributed to the annual value of $71.4 billion for FY2024, which is 2574.99% up from last year.
  • As of Q3 2025, Eli Lilly's Assets Average stood at $107.9 billion, which was up 4636.26% from $95.2 billion recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Assets Average peaked at $107.9 billion during Q3 2025, and registered a low of $46.7 billion during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $54.0 billion (2023), whereas its average is $61.8 billion.
  • In the last 5 years, Eli Lilly's Assets Average crashed by 153.23% in 2022 and then surged by 4636.26% in 2025.
  • Eli Lilly's Assets Average (Quarter) stood at $48.5 billion in 2021, then dropped by 0.04% to $48.5 billion in 2022, then increased by 25.76% to $61.0 billion in 2023, then grew by 26.57% to $77.2 billion in 2024, then soared by 39.88% to $107.9 billion in 2025.
  • Its last three reported values are $107.9 billion in Q3 2025, $95.2 billion for Q2 2025, and $84.1 billion during Q1 2025.